Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 9R2D7 | — |
| DTAP | DTAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine; Infanrix dose 3rd given on 15-JAN-2025 and Dtap 2nd dose on 15th October 2011; 13 years patient received Infanrix vaccine; has 2 previous doses of Dtap (September 14, 2011 and October 15, 2011); This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 13-year-old male patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis and DTPa (DTaP vaccine) for prophylaxis. Concomitant products included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (DTaP vaccine). On 15-JAN-2025, the patient received the 3rd dose of Infanrix. On an unknown date, the patient received Tdap Vaccine. On 15-OCT-2011, the patient received the 2nd dose of DTaP vaccine. On 15-OCT-2011, not applicable after receiving Infanrix and Tdap Vaccine and an unknown time after receiving DTaP vaccine, the patient experienced drug dose administration interval too short (Verbatim: has 2 previous doses of Dtap (September 14, 2011 and October 15, 2011)). On 15-JAN-2025, the patient experienced wrong vaccine administered (Verbatim: Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine), drug dose administration interval too long (Verbatim: Infanrix dose 3rd given on 15-JAN-2025 and Dtap 2nd dose on 15th October 2011) and inappropriate age at vaccine administration (Verbatim: 13 years patient received Infanrix vaccine). The outcome of the wrong vaccine administered, drug dose administration interval too long, inappropriate age at vaccine administration and drug dose administration interval too short were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-JAN-2025 The medical assistant reported that an Infanrix dose was given unintendedly to a patient who was supposed to receive a Tdap vaccine, which led to wrong vaccine administered. The patient had 2 previous doses of Dtap vaccine and no previous Tdap doses. The patient received a 3rd dose of Infanrix at an inappropriate age, which led to inappropriate age at vaccine administration. The patient received 3rd dose of Infanrix, later than the recommended interval, which led to lengthening of vaccination schedule. The patient received 2nd dose of DTaP earlier than recommended interval, which led to shortening of vaccination schedule. The Vaccine Administration Facility was the same as Primary Reporter.
DTaP vaccine